Based on our research findings, it is evident that the concentration of IL-6 significantly increased in patients with urolithiasis treated with URS on the first postoperative day, whereas there was no significant change in IL-6 levels in patients treated with ESWL. The gene discussed is IL6; the disease is urolithiasis.